Cristalfarma S.R.L.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Oct 2038
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
No maintenance fee falls due on this company's record before Nov 19, 2027.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 12,005,075 | Supplement for Mitigating Woman's Disorders Caused by Ageing In force · High confidence | In force | High confidence | |
| US 11,458,160 | Food Supplements for Use in the Prophylaxis and Treatment of Migraine In force · High confidence | In force | High confidence | |
| US 11,433,109 | Supplement for Mitigating Woman's Disorders Caused by Ageing In force · High confidence | In force | High confidence | |
| US 11,045,513 | Association of dry extracts of Vicia faba, Uncaria rhyncophylla and liquorice root together with coenzyme Q10 for use as coadjuvant, for improving the quality of life in subjects suffering from movement disorders In force · USPTO record | In force | USPTO record | |
| US 12,285,035 | Colonic release food supply as a coadjuvant in the treatment and prevention of colonic disorders caused by a suspected or confirmed alteration of the inflammatory pattern and microbiota destabilization In force · USPTO record | In force | USPTO record | |
| US 12,324,824 | Food supplement, for as adjuvant, for preventing vascular dementia In force · USPTO record | In force | USPTO record | |
| US 12,514,893 | A Food Supplement for Use as Coadjuvant in the Prevention and Treatment of Cognitive Decline Associated with Alzheimer Disease In force · High confidence | In force | High confidence |
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending